← Eichor
Study identifier: NCT06645262 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

First-degree Ankle Sprains

Condition: Ankle Sprain 1St Degree  ·  Sponsor: Rehabilitation Centre Zivot

PhaseN/A
Planned participants100
Who can joinAll sexes, 18 Weeks to no upper limit
Healthy volunteersNo

About this study

Grade I ankle sprains are common, especially among athletes, women, teenagers, and physically active individuals. While over a million cases are reported annually, this represents only half of the total occurrences. These injuries can lead to complications like chronic ankle instability or osteoarthritis. Treatment often involves conservative methods, including the PRICEMMS protocol (protection, rest, ice, compression, elevation, modalities, medication, and support), while surgery is reserved for severe cases. Therapeutic exercises and rehabilitation play a key role in recovery. The Bowen technique, effective for other musculoskeletal issues, has not yet been extensively studied for Grade I ankle sprains.

This description comes directly from the study's public registry record.

Talk to the study team

Darko Bilić, mag.fizio.  ·  +38763318139  ·  darkobilic@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Rehabilitation Centre ŽivotMostar, Bosnia and HerzegovinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06645262